USDA Recalls 143K Pounds of Popular Lunch Meat
The recall was issued after it was discovered that certain bologna products were mislabeled and may not clearly state the inclusion of pork, and in some cases, beef or chicken. The issue came to light following a complaint submitted through the Office of Inspector General's hotline.
The affected bologna was distributed under various brand names at both retail and wholesale outlets between March 20 and June 20. If you've purchased deli meat during this time frame, check your packaging for the following product names:
Family Tree Bologna Veal
Babushka's Recipe Chicken Bologna
Fancy Bologna
Gaiser's Russian Brand Doktorskaya Bologna
Gaiser's Bologna Veal
Gaiser's Turkey Bologna
Chicken Bologna Kypoyka Paba
All recalled products will feature the establishment number 'EST. 5385' inside the USDA inspection mark. You can also refer to product images available on the USDA website for easier identification.
Note: In addition to pre-packaged items, the recalled bologna may also have been sliced, wrapped, and labeled at grocery store deli counters.
While no illnesses or health issues have been reported so far, the USDA has classified this as a Class III recall, meaning the product is unlikely to cause harm if consumed. Still, caution is strongly advised.
If you've purchased any of the recalled bologna products—or bought deli-sliced bologna between March 20 and June 20 without clear labeling—you should avoid eating it. Instead, discard the product or return it to the store where it was purchased.
For additional information or questions about the recall, you can reach out to Gaiser's European Style Provisions Inc. at 908-686-3421 or via email at gaisers@verizon.net.
This isn't the first time Gaiser's European Style Provisions Inc. has come under scrutiny for mislabeled products. In October 2016, the company recalled approximately 3,895 pounds of chicken and pork bologna due to misbranding and undeclared allergens. The affected products contained nonfat dry milk, an allergen that was not listed on the label, and were also made with meat that had not undergone required federal inspection.
The recall included various bologna items, such as 'Gaiser's Russian Brand Professorskaya Bologna' and 'Gaiser's Chicken Bologna,' packaged in chub form and distributed to retail locations. All recalled items bore the establishment number 'EST. 5385' or 'P-5385' inside the USDA inspection mark and were produced between October 6 and October 20, 2016.
While no illnesses were reported at the time, the incident prompted a public advisory and urged consumers to discard or return the affected products. The similarities between the 2016 recall and the current one highlight ongoing challenges with labeling compliance and inspection protocols at the company.
Source: AllRecipes
Read the original article on GEEKSPIN. Affiliate links on GEEKSPIN may earn us and our partners a commission.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
Beach bacteria warnings plague Fourth of July weekend plans nationwide
Americans heading to the beach for Independence Day weekend may want to check if the waters are OK for swimming or wading. Warnings of high bacteria levels from public health officials have begun popping up in various states coast to coast. Vibrio is a bacterium that naturally lives in coastal waters, causing fever, vomiting, diarrhea, and cramps, according to the U.S. Centers for Disease Control and Prevention (CDC). On the West Coast, California officials in San Diego issued many warnings and closures of popular beaches, noting that some "bacteria levels exceed health standards." Two counties in Long Island, New York, have issued similar advisories. Suffolk County health officials posted, "Benjamin Beach in Bay Shore, Ronkonkoma Beach in the Town of Islip, and Sayville Marina Park Beach in Sayville are closed to bathing due to the finding of bacteria at levels in excess of acceptable criteria." The beaches will reopen when further testing reveals bacteria levels have dropped to acceptable levels, said the press release. Three Nassau County beaches — Hewlett Point, Island Park, and Phillip Healey Beach — are under advisory after heavy rainfall, according to the Nassau County Department of Health (NCDOH). Beaches will reopen when further testing reveals bacteria levels have dropped to acceptable levels. "Stormwater runoff may have impacted water quality at 3 South Shore beaches. As a precaution, NCDOH is advising against swimming at these locations. Stormwater runoff can raise bacteria levels, possibly exceeding NYS standards for safe bathing," said an NCDOH press release. In Massachusetts, nearly 20 beaches were closed as of Wednesday morning. Seventeen beaches are listed on the Massachusetts Department of Health "Beaches Dashboard," due to bacteria levels. Washington state lists advisories to "stay out of the water" at seven beaches with "high bacteria" in King County, according to its website. The Prairie State lists 34 advisories on their Illinois government website. There are 80,000 cases of the infection reported each year, according to the CDC. Michigan has nine beaches closed due to high bacteria levels from "wildlife" and "storm water runoff." Four beaches in the Great Lake State also have contamination advisories.
WIRED
2 hours ago
- WIRED
With RFK Jr. in Charge, Insurers Aren't Saying If They'll Cover Vaccines for Kids If Government Stops Recommending Them
Jul 2, 2025 10:25 AM RFK Jr.'s vaccine advisory board could stop recommending some routine childhood immunizations, leaving insurers to decide whether to still cover them. For now, most are remaining tight-lipped. Photograph:In the wake of the Advisory Committee on Immunization Practices (ACIP) announcing plans to revisit its recommended schedule for childhood vaccinations—a move that has drawn widespread criticism from experts—major insurers have not confirmed whether they'll continue to cover the full cost of routine shots for children. For 60 years ACIP has provided vaccine guidance to the Centers for Disease Control and Prevention (CDC), including on the timing and dosage of childhood immunizations. Insurers are required to cover the cost of most jabs on the recommended schedule for children. On Wednesday June 25, ACIP announced it would review the schedule, just weeks after health secretary and longtime anti-vaccine activist Robert F. Kennedy Jr. replaced the entire committee with his own appointees. When WIRED then asked 21 of the country's largest health insurance groups whether they would stop providing cost-free coverage of current routine immunizations in the event ACIP stops recommending them, only Blue Shield of California—a company in the Blue Cross Blue Shield Association—confirmed it would. 'As a payer our role is to ensure ongoing coverage and access to preventive, evidence-based care, including immunizations,' says company spokesperson Mark Seelig. 'Therefore, Blue Shield of California is committed to maintaining coverage of immunizations. The decision on whether to receive a vaccine is between our member and their provider.' Other large insurers, including UnitedHealthcare (which provides coverage for 50 million people), Cigna, Kaiser Permanente, Anthem, Humana, and Centene Corporation, did not respond to requests for comment. Blue Cross Blue Shield of Michigan said it had no comment. Most insurers that did respond said they were keeping an eye on developments in Washington, without indicating whether they would or would not cover vaccines dropped from the recommended schedule. 'Vaccines play an important role in the prevention of more serious illnesses,' says Phil Blando, a spokesperson at CVS Health, which owns the insurer Aetna. 'We are monitoring any changes the federal government makes to vaccination guidance and eligibility and will evaluate whether coverage adjustments are needed.' Highmark Inc., part of the Blue Cross Blue Shield Association, operating in Pennsylvania, Delaware, West Virginia, and New York, is also waiting to see what decision ACIP reaches. 'We are closely monitoring the evolving vaccine discussions occurring in Washington, DC. Various vaccines and immunizations are covered under Highmark's member benefits, with any future coverage considerations to be evaluated as more information becomes available,' says spokesperson Aaron Billger. Bryan Campen, of Health Care Service Corporation—the licensee of Blue Cross Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma, and Texas—notes that no changes have yet been made to the vaccines ACIP recommends or the company's vaccine coverage, but says that the company will 'continue to monitor any activity that may impact preventive care recommendations and will communicate any changes to recommendations that may impact standard coverage of preventive services.' Insurers had an eye on changes in ACIP guidance even before the committee announced it would revisit the schedule. 'As we navigate an evolving health care landscape, maintaining robust immunization coverage continues to be a top priority for protecting both individual and community health,' the industry's trade association, AHIP, said in a June 24 statement, the day before ACIP's announcement. 'We are committed to ongoing coverage of vaccines to ensure access and affordability for this respiratory virus season,' the statement continued. 'We encourage all Americans to talk to their health care provider about vaccines.' ACIP made headlines in early June when RFK Jr. fired all 17 of its members and replaced them with eight new appointees. (The HHS secretary appoints the committee's members, but conventionally they serve fixed 4-year terms.) These new appointees include Retsef Levi, who has stated—in the face of scientific consensus—that mRNA vaccines are deadly, and Robert Malone, who routinely shares articles about supposed links between cancer and the Covid vaccine, which no credible research has found to exist. Neither Levi nor Malone replied to a request for comment. Michael A. Ross, another recently appointed committee member, resigned from ACIP during a review of his financial holdings, the New York Times reported on June 24. When introducing his new ACIP appointees in a post on X earlier in June, RFK Jr. had described Ross as a faculty member at George Washington and Virginia Commonwealth universities—but spokespeople for the universities told NBC News4 that Ross had not taught at either in years. Ross did not reply to a request for comment. The committee made news again on June 25 when, during its first meeting of the year, it announced it would form a working group to review the recommended immunization schedule for children and teens. 'The number of vaccines that our children and adolescents receive today exceed what children in most other developed nations receive, and what most of us in this room received when we [were] children,' ACIP chair Martin Kulldorff said during the meeting. He noted that the group would examine the 'cumulative effect' of the recommended vaccine schedule, including interactions between vaccines, the total number of vaccines given, their timing, and recipients' exposure to vaccine ingredients. But the process for adding vaccines to the schedule is already rigorous. Before a vaccine can receive FDA licensure, its manufacturer must prove it does not negatively affect the safety or immune response of other vaccines administered at the same time on the schedule, says Paul Offit, director of the Children's Hospital of Philadelphia's Vaccine Education Center. In addition, 'the notion that these vaccines are somehow weakening your immune system or overwhelming your immune system is fanciful,' Offit says. Today, children are exposed to fewer viral or bacterial proteins in the first few years of the vaccine schedule than those in earlier generations. When Offit's parents received the smallpox vaccine, they were exposed to 200 proteins in a single shot. In contrast, the measles vaccine only contains 10. During the meeting, Kulldorff repeated claims he made in 2024 that he was fired from Harvard because he refused to get the Covid vaccine; he and Malone have also each served as paid expert witnesses in two separate suits against Merck over the safety of the company's HPV vaccine and its mumps vaccine, respectively. Kulldorff did not reply to a request for comment. The American Academy of Pediatrics (AAP) did not send representatives to last week's ACIP meeting, as it typically does. According to Academy president Susan Kressly, this was because the AAP believes the vaccine recommendation process lost credibility when its original membership was gutted by Kennedy. 'We won't lend our name or our expertise to a system that is being politicized at the expense of children's health,' Kressly said in a video posted online before the meeting was set to begin. The AAP did not reply to a request for comment about the video. The most recent child immunization schedule that the AAP endorses, from November 2024, is posted on the AAP website. A newer one, posted on the CDC site, has already changed recommendations. It no longer lists as 'routine' Covid vaccines for children under 18 who are not immunocompromised, but instead lists them under vaccines recommended for 'shared clinical decision-making,' informed by 'personal preference and circumstances.' The change should not affect insurance coverage.
Forbes
2 hours ago
- Forbes
UnitedHealth: Buy Or Sell UNH Stock At $325?
CANADA - 2025/04/06: In this photo illustration, the UnitedHealth Group logo is seen displayed on a ... More smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) UnitedHealth's stock (NYSE:UNH) has undergone a noticeable decline, decreasing from a peak of around $600 in April to about $275 in May, and then making a slight recovery to $325. This drop followed the company's announcement of disappointing Q1 results, the later retraction of its earnings forecast, and sudden shifts in top management. While these occurrences have naturally raised concerns regarding UNH stock, it is also trading at very appealing valuations. Additionally, as outlined below, the company exhibits robust operating performance and financial health across key metrics such as Growth, Profitability, Financial Stability, and Downturn Resilience. Nevertheless, for those investors who prefer less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having surpassed the S&P 500 and delivered returns greater than 91% since its inception. Separately, see – SOFI Stock To $30? How Does UnitedHealth's Valuation Look vs. The S&P 500? When considering what you pay per dollar of sales or profit, UNH stock appears inexpensive in relation to the broader market. How Have UnitedHealth's Revenues Grown Over Recent Years? UnitedHealth's Revenues have exhibited significant growth in recent years. How Profitable Is UnitedHealth? UnitedHealth's profit margins are significantly lower than those of most companies covered by Trefis. Does UnitedHealth Look Financially Stable? UnitedHealth's balance sheet appears robust. How Resilient Is UNH Stock During A Downturn? UNH stock has proven to be more resilient than the benchmark S&P 500 index during some recent downturns. As investors speculate on the possibility of a soft landing in the U.S. economy, how serious could it get if another recession strikes? Our dashboard How Low Can Stocks Go During A Market Crash shows how significant stocks fared during and after previous market crashes. Putting All The Pieces Together: What It Means For UNH Stock In conclusion, UnitedHealth's performance regarding the outlined metrics is as follows: UnitedHealth has shown strong performance across the previously mentioned parameters. This, in conjunction with its current low valuation, renders the stock appealing and reinforces our finding that UNH represents a worthwhile buying opportunity. Of course, there's always a level of uncertainty. In light of the recent challenges, including Centene's latest withdrawal of guidance, investors may be cautious about selecting UNH. However, for long-term investors, the presently discounted valuation is likely advantageous, especially given the company's consistent history of strong performance. While UNH stock appears promising, investing in a single stock can carry risks. Conversely, the Trefis High Quality (HQ) Portfolio, comprising 30 stocks, has a history of comfortably outperforming the S&P 500 over the last 4-year period. What accounts for this? Collectively, HQ Portfolio stocks produced superior returns with lower risk compared to the benchmark index; providing a less turbulent experience, as demonstrated by HQ Portfolio performance metrics.
